9:35am ET
Health and Healthcare
Top Health Care Earnings for the Week Ahead
Earnings season is hitting its stride next week, and the health care sector, the biotech stocks in particular, have been on a roll for the past 12 months.
Companies
/Healthcare
Lilly(Eli) & Company
$1,159.60
▼ $0.48 (−0.04%) today
Markets closed · 5:20am ET
LLY Coverage
Page 36
8:35am ET
Investing
Top Analyst Upgrades and Downgrades: Eli Lilly, Hertz, LinkedIn, NetApp, SINA, Vodafone, Wells Fargo and More
Wednesday's top analyst upgrades, downgrades and initiations include Eli Lilly, Hertz, LinkedIn, NetApp, SINA, Vodafone and Wells Fargo.
10:20am ET
Health and Healthcare
3 Top Big Pharmaceutical Stocks With Upcoming Catalysts
A new report from Jefferies updates the firm's top global pharmaceutical stocks to buy, and these picks make sense for investors now.
7:35am ET
Health and Healthcare
5 Big Upcoming FDA Decisions Expected in July
24/7 Wall St. has collected several big FDA decisions coming up on the calendar for the month of July and added some color.
9:05am ET
Investing
4 Merrill Lynch Catalyst-Driven Stock Ideas to Buy Now
A new research report from Merrill Lynch features the catalyst-driven stocks ideas for the third quarter. These four had the largest upside to the posted target prices.
11:35am ET
Health and Healthcare
Is Big Pharma Advertising Getting Out of Control?
How much are big pharmaceutical companies really spending to get their drugs out there in the public eye?
11:10am ET
Health and Healthcare
Are Cancer Drugs Becoming Too Costly for Their Effectiveness?
When the American Society of Clinical Oncology (ASCO) decided to create a rating scale for cancer drugs, it certainly must have expected to get some pushback.
9:25am ET
Investing
Top Analyst Upgrades and Downgrades: Amazon, CenturyLink, Fitbit, Mobileye, Eli Lilly, Netflix, AT&T and More
Thursday's top analyst upgrades, downgrades and initiations include Amazon, CenturyLink, Fitbit, Mobileye, Eli Lilly, Netflix and AT&T.
8:36am ET
Investing
4 Top New Growth Stock Picks From Jefferies
ThinkstockAs we get closer to second quarter earnings, many investors on Wall Street and Main Street are starting to concentrate on having stocks in portfolios that can not only hit or beat…
11:45am ET
Health and Healthcare
Key Analyst Sees Solid Upside in Eli Lilly
Eli Lilly has made a big splash in the market over the past year. A key analyst sees this trend continuing despite some potential near-term headwinds.
Chris Lange 8:45am ET
Investing
Top Analyst Upgrades and Downgrades: Bankrate, Eli Lilly, Embraer, Oracle, Southwest Air and More
Thursday's top analyst upgrades, downgrades and initiations include Bankrate, Eli Lilly, Embraer, Oracle and Southwest Airlines.
8:50am ET
Investing
Top Analyst Upgrades and Downgrades: Arista, Baidu, Chevron, Lexmark, Occidental, Salesforce and More
Wednesday's top analyst upgrades, downgrades and initiations include Arista Networks, Baidu, Chevron, Lexmark International, Occidental Petroleum and Salesforce.com.
9:05am ET
Investing
5 Top Performers for the Past Week
24/7 Wall St. has put together a list of companies that have outperformed the market this past week.
1:00pm ET
Health and Healthcare
Autoimmune Drugs to Drive Big Pharma Higher in Coming Years
Credit Suisse has updated its autoimmune market model and it sees implications for all of the large cap U.S. pharmaceutical companies in its coverage.
9:15am ET
Health and Healthcare
Jefferies Makes Changes to Top Pharmaceutical Stocks to Buy
With major mergers and acquisition deals happening, and a host of clinical trials that could offer some outstanding breakthrough drug treatments, the big pharmaceutical stocks have had their fair share of attention…